Z-2226-2017 Class I Terminated
FDA device recall Z-2226-2017 was initiated by Magellan Diagnostics, Inc. on May 23, 2017 and is designated Class I. Reason for recall: Underestimates the lead concentration of venous blood samples when the sample is analyzed with the LeadCare systems The recall status is terminated (terminated July 8, 2021). Affected quantity: 6018 kits (total)= 5818 (US)and 200 (OUS).
Recall Details
- Product Type
- Devices
- Report Date
- June 14, 2017
- Initiation Date
- May 23, 2017
- Termination Date
- July 8, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6018 kits (total)= 5818 (US)and 200 (OUS)
Product Description
Reason for Recall
Distribution Pattern
Worldwide Distribution - US (Nationwide) Foreign: AUSTRALIA AUSTRIA BOLIVIA CANADA CHILE CHINA COLOMBIA DOMINICAN REPUB ENGLAND GERMANY INDIA UK ISRAEL ITALY JAPAN KOREA MALI MYANMAR SPAIN NEPAL NETHERLANDS NEW ZEALAND P.R. CHINA PANAMA US PERU PHILLIPINES POLAND PORTUGAL REP OF KOSOVO SOUTH AFRICA SRI LANKA USA SWEDEN SWITZERLAND TRINIDAD UNITED ARAB EMI VIETNAM